Animal studies have failed to reveal evidence of teratogenicity. There are no controlled data in human pregnancy.

AU TGA pregnancy category B2: Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed. Studies in animals are inadequate or may be lacking, but available data show no evidence of an increased occurrence of fetal damage.

Use should be avoided when possible.
-According to some authorities: This drug should be used during pregnancy only if the benefit outweighs the risk.

AU TGA pregnancy category: B2
US FDA pregnancy category: Not formally assigned to a pregnancy category.

Comments:
-Some manufacturers recommend pregnant women consult their physician before use of this drug; according to some manufacturers, this drug should not be used unless directed by a physician.

See references

Safety has not been established; according to some experts, use is considered acceptable.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments:
-No data available on the use of this drug during breastfeeding.
-The effects in the nursing infant are unknown.
-This drug is poorly absorbed orally; excretion into breast milk and absorption by nursing infants are unlikely.

See references